- Anderson DR, Patil SM, Kamina A, Penson DF, Peduzzi P, Concato J. Validation and modification of a staging system for evaluating prognosis in prostate cancer. Connecticut Medicine. 64(8):459-464, 2000.
- Shope JT, Waller PF, Raghunathan TE, Patil S. Adolescent antecedents of high-risk driving behavior in young adulthood: substance use and parental influences. Accident Analysis and Prevention. 33: 649-658, 2001.
- Shope JT, Raghunathan TE, Patil SM. Examining trajectories of adolescent risk factors as predictors of subsequent high-risk driving behavior. Journal of Adolescent Health. 32(3): 214-224, 2003.
- Gross SR, Jacoby K, Matheson DJ, Montgomery N, Patil SM. Exonerations in the United States 1989 through 2003, Journal of Criminal Law and Criminology. 95(2) 2005.
- Davis JA, McBride MG, Chrisant MRK, Patil SM, Hanna BD, Paridon SM. Longitudinal assessment of cardiovascular exercise performance after pediatric heart transplantation. The Journal of Heart and Lung Transplantation, 25(6):626-633, 2006.
- Steenhoff AP, Shah SS, Ratner AJ, Patil SM, McGowan KL. Emergence of vaccine-related pneumococcal serotypes as a cause of bacteremia. Clinical Infectious Diseases, 42:907-914, 2006.
- Steenhoff AP, Shah SS, Ratner AJ, Patil SM, McGowan KL. Reply to Robertson et al. Clinical Infectious Diseases, 43:544-545, 2006.
- Patil SM, Raghunathan TE, Shope JT. Role of personality traits in young-adult high risk driving. Traffic Injury Prevention,7(4):328-334, 2006.
- Barrio AV, Clark BD, Goldberg JI, Hoque LW, Bernik SF, Flynn LW, Susnik B, Giri D, Polo K, Patil SM, Van Zee KJ. Clinicopathologic features and long-term outcomes of 293 phyllodes tumors of the breast. Annals of Surgical Oncology, 14(10): 2961-2970, 2007.
- Hurria A, Lichtman SM, Gardes J, Li D, Limaye S, Patil SM, Zuckerman E, Tew W, Hamlin P, Abou-Alfa GK, Lachs M, Kelly E. Identifying vulnerable older adults with cancer: integrating geriatric assessment into oncology practice. Journal of the American Geriatrics Society, 55(10): 1604-1608, 2007.
- Feldman DR, Kondagunta GV, Ginsberg MS, Ishill N, Patil SM, Cestaro J, Obens E, Sheinfeld J, Bosl GJ, Motzer RJ. Phase II Trial of ixabepilone in patients with cisplatin-refractory germ cell tumors. Investigational New Drugs. 25(5): 487-490, 2007.
- Chelliah A, Heydon KH, Zaotis TE, Rettig SL, Dominguez TE, Lin R, Patil SM, Feudtner C, St John KH, Bell LM, Coffin SE. Observational trial of antibiotic-coated central venous catheters in critically ill pediatric patients. Journal of Pediatric Infectious Diseases. 26(9): 816-820, 2007.
- Fornier M, Rathkopf D, Shah M, Patil SM, O'Reilly E, Tse A, Hudis C, Kelsen DP, Schwartz. Phase I dose-finding study of weekly docetaxel followed by flavopiridol for patients with advanced solid tumors, CCR-07-1218 Version 2. Clinical Cancer Research 13(19): 5841-5846, 2007.
- Dang C, Patil SM. Lack of benefit of maintenance paclitaxel in first-line chemotherapy in metastatic breast cancer. Letter in response to Gennari et al Journal of Clinical Oncology 24: 3912-3918, 2006. Breast Diseases: A Yearbook Quarterly 18(3): 305, 2007.
- McLaughlin SA, Ochoa-Frongia LM, Patil SM, Cody HS, Sclafani LM. Influence of frozen-section analysis of sentinel lymph node and lumpectomy margin status on reoperation rates in patients undergoing breast-conservation therapy. Journal of American College of Surgeons. 206(1): 76-82, 2008.
- Roohipour R, Patil SM, Goodman KA, Minsky B, Wong WD, Guillem JG, Paty PB, Weiser MR, Neuman HB, Shia J, Schrag D, Temple LKF. Squamous cell carcinoma of the anal canal: predictors of treatment outcome. Diseases of the Colon and Rectum. 51(2): 147-53, 2008.
- Traina TA, Theodoulou M, Feigin F, Patil SM, Tan KL, Edwards C, Dugan U, Norton L, Hudis C. Phase I study of a novel capecitabine schedule based upon the Norton-Simon mathematical model in patients with metastatic breast cancer. Journal of Clinical Oncology. 26(11): 1797-1802, 2008.
- Flynn LW, Park J, Patil SM, Cody III HS, Port ER. Sentinel Lymph Node Biopsy Is Successful and Accurate in Male Breast Carcinoma. Journal of the American College of Surgeons. Journal of the American College of Surgeons, 206(4) 616-621, 2008.
- Jathavedam A, Feldman D, Ishill N, Patil SM, Bosl GJ, Motzer RM, Weinstock DM. Infectious Complications from High-Dose Chemotherapy and Autologous Stem Cell Transplantation for Metastatic Germ Cell Tumors. Biology of Blood and Marrow Transplantation, 14(5), 595-600.
- Feldman DR, Kondagunta GV, Schwartz L, Patil SM, Ishill N, DeLuca J, Russo P, Motzer RJ. Phase II trial of pegylated interferion-alpha 2b in patients with advanced renal cell carcinoma. Clinical Genitourinary Cancer, 6(1), 25-30, 2008.
- Chung A, Yu J, Stempel M, Patil S, Cody H, Montgomery L. Is the "10% rule" equally valid for all subsets of sentinel-node-positive breast cancer patients? Ann Surg Oncol. 2008 Oct;15(10):2728-33. Epub 2008 Aug 8.
- Rudloff U, Brogi E, Brockway JP, Goldberg JI, Cranor M, Wynveen CA, Nehhozinam T, Reiner AS, Patil S, Van Zee KJ. Concurrent lobular neoplasia increases the risk of ipsilateral breast cancer recurrence in patients with ductal carcinoma in situ treated with breast-conserving therapy. Cancer. 2009 Mar 15;115(6):1203-14.
- Feldman DR, Baum MS, Ginsberg MS, Hassoun H, Flombaum CD, Velasco S, Fischer P, Ronnen E, Ishill N, Patil S, Motzer RJ. Phase I trial of bevacizumab plus escalated doses of sunitinib in patients with metastatic renal cell carcinoma. J Clin Oncol. 2009 Mar 20;27(9):1432-9. Epub 2009 Feb 17.
- Patil SM, Xu S, Sheftic SR, Alexandrescu AT. Dynamic alpha-helix structure of micelle-bound human amylin. J Biol Chem. 2009 May 1;284(18):11982-91. Epub 2009 PMCID: PMC2673267.
- Temple L, Fuzesi S, Patil S. The importance of determining quality of life in clinical trials. Surgery. 2009 Jun;145(6):622-6. Epub 2009 Apr 16.
- Feldman DR, Turkula S, Ginsberg MS, Ishill N, Patil S, Carousso M, Bosl GJ, Motzer RJ. Phase II trial of sunitinib in patients with relapsed or refractory germ cell tumors. Invest New Drugs. 2009 Jun 23. [Epub ahead of print]
- Karam AK, Hsu M, Patil S, Stempel M, Traina TA, Ho AY, Cody HS, Port ER, Morrow M, Gemignani ML. Predictors of completion axillary lymph node dissection in patients with positive sentinel lymph nodes. Ann Surg Oncol. 2009 Jul;16(7):1952-8. Epub 2009 Apr 18.
- Poultsides GA, Servais EL, Saltz LB, Patil S, Kemeny NE, Guillem JG, Weiser M, Temple LK, Wong WD, Paty PB. Outcome of primary tumor in patients with synchronous stage IV colorectal cancer receiving combination chemotherapy without surgery as initial treatment. J Clin Oncol. 2009 Jul 10;27(20):3379-84. Epub 2009 Jun 1.
- Kalinsky K, Jacks LM, Heguy A, Patil S, Drobnjak M, Bhanot UK, Hedvat CV, Traina TA, Solit D, Gerald W, Moynahan ME. PIK3CA mutation associates with improved outcome in breast cancer. Clin Cancer Res. 2009 Aug 15;15(16):5049-59. Epub 2009 Aug 11.
- Zauderer M, Patil S, Hurria A. Feasibility and toxicity of dose-dense adjuvant chemotherapy in older women with breast cancer. Breast Cancer Res Treat. 2009 Sep;117(1):205-10. Epub 2008 Jul 13.
- Hurria A, Li D, Hansen K, Patil S, Gupta R, Nelson C, Lichtman SM, Tew WP, Hamlin P, Zuckerman E, Gardes J, Limaye S, Lachs M, Kelly E. Distress in older patients with cancer. J Clin Oncol. 2009 Sep 10;27(26):4346-51. Epub 2009 Aug 3.
- Wiechmann L, Sampson M, Stempel M, Jacks LM, Patil SM, King T, Morrow M. Presenting features of breast cancer differ by molecular subtype. Ann Surg Oncol. 2009 Oct;16(10):2705-10. Epub 2009 Jul 11.
- Traina TA, Rugo HS, Caravelli JF, Patil S, Yeh B, Melisko ME, Park JW, Geneus S, Paulson M, Grothusen J, Seidman AD, Fornier M, Lake D, Dang C, Robson M, Theodoulou M, Flombaum CD, Norton L, Hudis CA, Dickler MN. Feasibility Trial of Letrozole in Combination With Bevacizumab in Patients With Metastatic Breast Cancer. J Clin Oncol. 2009 Oct 19. [Epub ahead of print]
- Korkola JE, Houldsworth J, Feldman DR, Olshen AB, Qin LX, Patil S, Reuter VE, Bosl GJ, Chaganti RS. Identification and validation of a gene expression signature that predicts outcome in adult men with germ cell tumors. J Clin Oncol. 2009 Nov 1;27(31):5240-7. Epub 2009 Sep 21.
- Patil S, Ishill N, Deluca J, Motzer RJ. Stage migration and increasing proportion of favorable-prognosis metastatic renal cell carcinoma patients: implications for clinical trial design and interpretation. Cancer. 2009 Nov 17.[Epub ahead of print]
- Pugliese MS, Karam AK, Hsu M, Stempel MM, Patil SM, Ho AY, Traina TA, Van Zee KJ, Cody HS 3rd, Morrow M, Gemignani ML. Predictors of Completion Axillary Lymph Node Dissection in Patients With Immunohistochemical Metastases to the Sentinel Lymph Node in Breast Cancer. Ann Surg Oncol. 2009 Dec 22. [Epub ahead of print]
|
